NANO-X IMAGING (NNOX)

Nasdaq Markedet er stengt

Nano-X Imaging Ltd is a medical imaging technology company that seeks to broaden access to diagnostic imaging and support earlier detection of disease. The company’s platform combines imaging hardware, cloud-based infrastructure, artificial intelligence tools, radiology services, and healthcare information technology, positioning it at the intersection of medical devices, software, and outsourced clinical services.

Its best-known hardware initiative is the Nanox.ARC, an imaging system designed as a more accessible alternative to conventional medical imaging equipment. The broader Nanox model is not limited to the scanner itself. The company also develops software intended to connect imaging sites, radiologists, and healthcare providers, while its AI tools are designed to assist with the analysis of medical images and help identify conditions that may require clinical follow-up.

Nano-X Imaging reports its activities through three main areas: the Nanox.ARC segment, the AI and software solutions segment, and the radiology services segment. The radiology services business is an important revenue contributor, reflecting the company’s role in supporting image interpretation and related workflow services for healthcare providers. This gives Nano-X exposure not only to future adoption of its own imaging hardware, but also to ongoing demand for outsourced radiology capacity.

For investors, NNOX is a healthcare technology stock tied to the long-term themes of preventive care, imaging accessibility, artificial intelligence in diagnostics, and cloud-enabled clinical workflows. Its investment case depends on regulatory progress, commercial deployment, adoption by healthcare systems, and the company’s ability to prove that its integrated platform can deliver reliable imaging, efficient interpretation, and economically attractive services at scale.

1.93 USD
1.93 USD
−0.14 (-6.76%)
Etter stengetid

Sist oppdatert

Markedsverdi
P/E-tall
P/FCF-tall
P/S-tall
Selskapsverdi
Sektor
Bransje
Adresse
GlobeNewswire Inc.

NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.

06. mai 2026, 00:00 A.M.
GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX

28. apr. 2026, 23:40 P.M.
GlobeNewswire Inc.

NNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

28. apr. 2026, 02:22 A.M.
GlobeNewswire Inc.

NNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall Law Firm

27. apr. 2026, 04:30 A.M.
GlobeNewswire Inc.

NANO-X INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nano-X Imaging Ltd. on Behalf of Nano-X Stockholders and Encourages Investors to Contact the Firm

23. apr. 2026, 23:40 P.M.
GlobeNewswire Inc.

Nanox Announces $15 Million Registered Direct Offering of Common Stock

24. nov. 2025, 05:26 A.M.
GlobeNewswire Inc.

Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging

18. sep. 2025, 14:00 P.M.
GlobeNewswire Inc.

Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication

05. des. 2024, 11:55 A.M.
GlobeNewswire Inc.

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

25. juni 2024, 14:00 P.M.
Zacks Investment Research

Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?

20. juni 2024, 15:40 P.M.
Zacks Investment Research

Down -19.76% in 4 Weeks, Here's Why NanoX Imaging (NNOX) Looks Ripe for a Turnaround

19. juni 2024, 15:35 P.M.
Zacks Investment Research

Bears are Losing Control Over NanoX Imaging (NNOX), Here's Why It's a 'Buy' Now

12. juni 2024, 15:55 P.M.
GlobeNewswire Inc.

Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform

05. juni 2024, 14:00 P.M.
GlobeNewswire Inc.

USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission

08. mai 2024, 14:00 P.M.
GlobeNewswire Inc.

Nanox Files 2023 Annual Report on Form 20-F

22. apr. 2024, 15:40 P.M.
GlobeNewswire Inc.

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

09. apr. 2024, 14:40 P.M.
GlobeNewswire Inc.

Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

18. mars 2024, 13:30 P.M.
GlobeNewswire Inc.

Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold

12. mars 2024, 13:45 P.M.
GlobeNewswire Inc.

Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases

29. feb. 2024, 14:00 P.M.
Zacks Investment Research

All Eyes on Nvidia Earnings: Here's What to Expect

21. feb. 2024, 16:43 P.M.

Resultatregnskap

Post 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Omsetning
Bruttofortjeneste
Driftsresultat
Driftsresultat før avskrivninger (EBITDA) 0 0 0 0 0
Nettoresultat
Grunnleggende EPS
Utvanet EPS

Balanse

Post 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Sum eiendeler 162.17M 210M 218.65M 253.93M 363.17M
Sum gjeld 22.43M 20.88M 23.13M 37.25M 71.02M
Egenkapital 139.73M 189.12M 195.51M 216.68M 292.15M
Kontanter og ekvivalenter 49.15M 39.3M 56.38M 38.46M 66.65M
Omløpsmidler 66.79M 78.68M 88.59M 82.46M 94.86M
Kortsiktig gjeld 16.89M 13.97M 15.52M 25.07M 52.75M

Kontantstrøm

Post 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Kontantstrøm fra drift
Kontantstrøm fra investeringer
Kontantstrøm fra finansiering
Endring i kontanter
Type Rapport Dato Lenke
edgar index SCHEDULE 13G/A — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
form 3 Form 3 — Yahav Attias Gali Vis rapport
form 3 Form 3 — Yahav Attias Gali Vis rapport
form 3 Form 3 — Yahav Attias Gali Vis rapport
form 3 Form 3 — Yahav Attias Gali Vis rapport
form 3 Form 3 — Yahav Attias Gali Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
form 3 Form 3 — Alroy Erez Vis rapport
form 3 Form 3 — Alroy Erez Vis rapport
form 3 Form 3 — Alroy Erez Vis rapport
form 3 Form 3 — Alroy Erez Vis rapport
form 3 Form 3 — saban sharon Vis rapport
form 3 Form 3 — saban sharon Vis rapport
edgar index CORRESP — Nano-X Imaging Ltd. Vis rapport
edgar index F-3/A — Nano-X Imaging Ltd. Vis rapport
edgar index 4 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
form 3 Form 3 — Ronen Nehama Vis rapport
form 3 Form 3 — Ronen Nehama Vis rapport
form 3 Form 3 — Ronen Nehama Vis rapport
edgar index UPLOAD — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
form 3 Form 3 — Kainan Noga Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
edgar index 3 — Nano-X Imaging Ltd. Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Aharon Cohen Tamar Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Koren Ofir Vis rapport
form 3 Form 3 — Jackman Michael Vis rapport
form 3 Form 3 — Jackman Michael Vis rapport
form 3 Form 3 — Jackman Michael Vis rapport
form 3 Form 3 — Gofman Feler Marina Vis rapport
form 3 Form 3 — Gofman Feler Marina Vis rapport
form 3 Form 3 — Gofman Feler Marina Vis rapport
form 3 Form 3 — Gofman Feler Marina Vis rapport
form 3 Form 3 — Gofman Feler Marina Vis rapport
form 3 Form 3 — Dara James Vis rapport
form 3 Form 3 — Dara James Vis rapport
form 3 Form 3 — Dara James Vis rapport
form 3 Form 3 — Dara James Vis rapport
form 3 Form 3 — Dara James Vis rapport
form 3 Form 3 — Meltzer Erez Vis rapport
form 3 Form 3 — Meltzer Erez Vis rapport
form 3 Form 3 — Meltzer Erez Vis rapport
form 3 Form 3 — Meltzer Erez Vis rapport
form 4 Form 4 — Daniel Ran Vis rapport
edgar index F-3 — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 424B5 — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport
edgar index 6-K — Nano-X Imaging Ltd. Vis rapport